Quanterix (QTRX) Return on Capital Employed (2018 - 2026)
Quanterix (QTRX) posted Return on Capital Employed of 41.0% for Q1 2026, down 16.48% on a QoQ basis from 35.2% in Q4 2025, and down 2332.0% year-over-year from 1.84% in Q1 2025.
Quanterix (QTRX) Return on Capital Employed (2018 - 2026) Analysis & Trends
Quanterix's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 41.0% for Q1 2026.
- Quarterly Return on Capital Employed fell 2332.0% year-over-year to 41.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 41.0% (down 2332.0% YoY) and the FY2025 annual result came in at 37.15%, down 2314.0% from the prior year.
- Return on Capital Employed was 41.0% for Q1 2026 at Quanterix, down from 35.2% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 11.8% in Q4 2023 and bottomed at 41.0% in Q1 2026.
- A 5-year average of 21.11% and a median of 17.67% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed surged 1375 bps — and 2026, when it sank 2332 bps.
- Quanterix's Return on Capital Employed stood at 25.54% in 2022, then soared by 54 bps to 11.8% in 2023, then dropped by 22 bps to 14.35% in 2024, then tumbled by 145 bps to 35.2% in 2025, then declined by 16 bps to 41.0% in 2026.
- Business Quant data shows QTRX's Return on Capital Employed at 41.0% in Q1 2026, 35.2% in Q4 2025, and 34.75% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -41.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.00% |
| Dec 31, 2025 | -35.20% |
| Sep 30, 2025 | -34.75% |
| Jun 30, 2025 | -26.63% |
| Mar 31, 2025 | -17.67% |
| Dec 31, 2024 | -14.35% |
| Sep 30, 2024 | -13.65% |
| Jun 30, 2024 | -13.94% |
| Mar 31, 2024 | -13.01% |
| Dec 31, 2023 | -11.80% |
| Sep 30, 2023 | -13.69% |
| Jun 30, 2023 | -20.01% |
| Mar 31, 2023 | -24.09% |
| Dec 31, 2022 | -25.54% |
| Sep 30, 2022 | -22.98% |
| Jun 30, 2022 | -16.92% |
| Mar 31, 2022 | -13.69% |
| Dec 31, 2021 | -12.05% |
| Sep 30, 2021 | -9.96% |
| Jun 30, 2021 | -6.31% |